Orhan Adalı

800 total citations
42 papers, 654 citations indexed

About

Orhan Adalı is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Orhan Adalı has authored 42 papers receiving a total of 654 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Pharmacology and 7 papers in Oncology. Recurrent topics in Orhan Adalı's work include Pharmacogenetics and Drug Metabolism (12 papers), Glutathione Transferases and Polymorphisms (9 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). Orhan Adalı is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Glutathione Transferases and Polymorphisms (9 papers) and Genomics, phytochemicals, and oxidative stress (7 papers). Orhan Adalı collaborates with scholars based in Türkiye, Serbia and United Kingdom. Orhan Adalı's co-authors include Emel Arınç, Serdar Karakurt, Birsen Can Demirdöğen, Şeref Demirkaya, Şevki Arslan, Semai Bek, Alaattin Şen, Aslı Semiz, Azra Bozcaarmutlu and Ayşe Mine Gençler Özkan and has published in prestigious journals such as Archives of Biochemistry and Biophysics, Gene and Behavioural Brain Research.

In The Last Decade

Orhan Adalı

42 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orhan Adalı Türkiye 16 238 176 78 77 76 42 654
Woon‐Gye Chung South Korea 18 391 1.6× 291 1.7× 107 1.4× 58 0.8× 61 0.8× 28 955
Eric Gumpricht United States 20 357 1.5× 243 1.4× 217 2.8× 82 1.1× 38 0.5× 44 1.1k
Feral Öztürk Türkiye 16 182 0.8× 231 1.3× 56 0.7× 177 2.3× 32 0.4× 41 938
Asjad Visnagri United Kingdom 11 285 1.2× 142 0.8× 46 0.6× 74 1.0× 48 0.6× 15 886
Mohamed A. El‐Moselhy Egypt 19 294 1.2× 116 0.7× 107 1.4× 54 0.7× 45 0.6× 39 975
Yenjerla Mythili India 19 320 1.3× 93 0.5× 66 0.8× 109 1.4× 20 0.3× 22 796
Claudia María Martínez‐Martínez Mexico 14 224 0.9× 79 0.4× 55 0.7× 179 2.3× 31 0.4× 19 752
Yadollah Azarmi Iran 17 258 1.1× 111 0.6× 183 2.3× 84 1.1× 20 0.3× 43 942
I. Grattagliano Italy 16 342 1.4× 57 0.3× 54 0.7× 47 0.6× 150 2.0× 24 1.0k
MOHAMED H. ABDEL-WAHAB Egypt 8 193 0.8× 188 1.1× 100 1.3× 123 1.6× 48 0.6× 9 1.1k

Countries citing papers authored by Orhan Adalı

Since Specialization
Citations

This map shows the geographic impact of Orhan Adalı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Adalı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Adalı more than expected).

Fields of papers citing papers by Orhan Adalı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orhan Adalı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Adalı. The network helps show where Orhan Adalı may publish in the future.

Co-authorship network of co-authors of Orhan Adalı

This figure shows the co-authorship network connecting the top 25 collaborators of Orhan Adalı. A scholar is included among the top collaborators of Orhan Adalı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orhan Adalı. Orhan Adalı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ege, T., Ayşe Mine Gençler Özkan, Alaattin Şen, & Orhan Adalı. (2018). Effects of folk medicinal plant epilobium hirsutum l. And its ingredient ellagic acid on rat liver bile acid synthesizing cyps in rats. Pamukkale University Open Access Archive (Pamukkale University). 2 indexed citations
2.
3.
Karakurt, Serdar & Orhan Adalı. (2016). Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes. Anti-Cancer Agents in Medicinal Chemistry. 16(6). 781–789. 52 indexed citations
4.
Karakurt, Serdar, et al.. (2015). Alteration of enzyme activities and kinetic properties of GST and NQO1 with naturally occurring phenolic compounds. Turkish Journal of Biochemistry. 40(3). 251–257. 2 indexed citations
5.
Karakurt, Serdar, et al.. (2015). Contribution of ellagic acid on the antioxidant potential of medicinal plantEpilobium hirsutum. Nutrition and Cancer. 68(1). 173–183. 16 indexed citations
6.
Demirdöğen, Birsen Can, et al.. (2014). Importance of NOS3 Genetic Polymorphisms in the Risk of Development of Ischemic Stroke in the Turkish Population. Genetic Testing and Molecular Biomarkers. 18(12). 797–803. 6 indexed citations
7.
Demirdöğen, Birsen Can, et al.. (2013). Flavin containing monooxygenase 3 genetic polymorphisms Glu158Lys and Glu308Gly and their relation to ischemic stroke. Gene. 521(1). 116–121. 13 indexed citations
8.
Karakurt, Serdar, et al.. (2013). Epilobium hirsutumalters xenobiotic metabolizing CYP1A1, CYP2E1, NQO1 and GPx activities, mRNA and protein levels in rats. Pharmaceutical Biology. 51(5). 650–658. 17 indexed citations
9.
10.
Karakurt, Serdar, et al.. (2012). Correlation between hippocampal levels of neural, epithelial and inducible NOS and spatial learning skills in rats. Behavioural Brain Research. 235(2). 326–333. 22 indexed citations
11.
Demirdöğen, Birsen Can, et al.. (2012). Apolipoprotein A5 polymorphisms in Turkish population: association with serum lipid profile and risk of ischemic stroke. Molecular Biology Reports. 39(12). 10459–10468. 15 indexed citations
12.
Demirdöğen, Birsen Can, et al.. (2010). Association analysis of GSTT1, GSTM1 genotype polymorphisms and serum total GST activity with ischemic stroke risk. Neurological Sciences. 31(6). 727–734. 31 indexed citations
13.
Demirdöğen, Birsen Can, Semai Bek, Yavuz Sanısoğlu, et al.. (2007). Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Clinical Biochemistry. 41(1-2). 1–9. 51 indexed citations
14.
Arınç, Emel, et al.. (2007). Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Archives of Toxicology. 81(10). 711–718. 40 indexed citations
15.
16.
Arınç, Emel, Şevki Arslan, Azra Bozcaarmutlu, & Orhan Adalı. (2006). Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food and Chemical Toxicology. 45(1). 107–118. 47 indexed citations
17.
Demirdöğen, Birsen Can & Orhan Adalı. (2004). Characterization and modulation by drugs of sheep liver microsomal flavin monooxygenase activity. Cell Biochemistry and Function. 23(4). 245–251. 10 indexed citations
18.
Arınç, Emel, Orhan Adalı, & Ayşe Mine Gençler Özkan. (2000). Stimulation of aniline, p -nitrophenol and N -nitrosodimethylamine metabolism in kidney by pyridine pretreatment of rabbits. Archives of Toxicology. 74(9). 527–532. 12 indexed citations
19.
Adalı, Orhan, et al.. (1998). Characterization of beta-galactosidase immobilized into poly(hydroxyethylmethacrylate) membranes. OpenMETU (Middle East Technical University). 14(2). 123–129. 4 indexed citations
20.
Adalı, Orhan, et al.. (1998). Modulation of Human Flavin-Containing Monooxygenase 3 Activity by Tricyclic Antidepressants and Other Agents: Importance of Residue 428. Archives of Biochemistry and Biophysics. 358(1). 92–97. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Woon‐Gye Chung Breakdown of academic impact, for papers by Eric Gumpricht Breakdown of academic impact, for papers by Feral Öztürk Breakdown of academic impact, for papers by Asjad Visnagri Breakdown of academic impact, for papers by Mohamed A. El‐Moselhy Breakdown of academic impact, for papers by Yenjerla Mythili Breakdown of academic impact, for papers by Claudia María Martínez‐Martínez Breakdown of academic impact, for papers by Yadollah Azarmi Breakdown of academic impact, for papers by I. Grattagliano Breakdown of academic impact, for papers by MOHAMED H. ABDEL-WAHAB
Rankless by CCL
2026